Thermo Fisher Scientific Inc (TMO)

Debt-to-capital ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	49,551,000	48,992,000	47,432,000	45,516,000	46,724,000	45,328,000	43,752,000	42,257,000	43,978,000	43,549,000	42,293,000	40,956,000	40,793,000	38,710,000	36,854,000	35,058,000	34,507,000	31,824,000	29,875,000	28,559,000
Debt-to-capital ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $49,551,000K)
= 0.00

Thermo Fisher Scientific Inc has consistently maintained a debt-to-capital ratio of 0.00 across all reported quarters from March 31, 2020, to December 31, 2024. This indicates that the company has not used debt significantly to finance its operations or growth relative to its total capital structure. A low debt-to-capital ratio suggests that the company may have a strong balance sheet with a lower financial risk as it relies more on equity financing rather than debt financing. Thermo Fisher Scientific Inc's consistent 0.00 debt-to-capital ratio indicates a conservative approach to capital structure management and a stable financial position over the analyzed period.